2seventy bio, Inc. (TSVT)
NASDAQ: TSVT · Real-Time Price · USD
3.610
+0.450 (14.24%)
Nov 22, 2024, 4:00 PM EST - Market closed
2seventy bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | 45.62 | 100.39 | 91.5 | 54.52 | 248.12 | 44.3 | Upgrade
|
| Revenue Growth (YoY) | -68.73% | 9.72% | 67.81% | -78.03% | 460.15% | -18.84% | Upgrade
|
| Cost of Revenue | 136.35 | 247.68 | 274.95 | 274.53 | 301.86 | 300.62 | Upgrade
|
| Gross Profit | -90.73 | -147.29 | -183.46 | -220 | -53.74 | -256.33 | Upgrade
|
| Selling, General & Admin | 51.6 | 69.41 | 79.45 | 93.51 | 90.9 | 81.65 | Upgrade
|
| Operating Expenses | 51.6 | 69.41 | 79.45 | 93.51 | 90.9 | 81.65 | Upgrade
|
| Operating Income | -142.33 | -216.7 | -262.91 | -313.51 | -144.64 | -337.97 | Upgrade
|
| Interest & Investment Income | 11.89 | 12.41 | 2.93 | 0.09 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 2.7 | 7.63 | 6.06 | 21.65 | 18.06 | 20.13 | Upgrade
|
| EBT Excluding Unusual Items | -127.74 | -196.67 | -253.92 | -291.77 | -126.58 | -317.85 | Upgrade
|
| Merger & Restructuring Charges | -12.13 | -8.61 | - | - | - | - | Upgrade
|
| Impairment of Goodwill | - | -12.06 | - | - | - | - | Upgrade
|
| Other Unusual Items | 2.36 | -0.24 | -0.23 | -0.44 | 6.47 | -2.75 | Upgrade
|
| Pretax Income | -94.55 | -217.57 | -254.15 | -292.21 | -120.11 | -320.59 | Upgrade
|
| Net Income | -94.55 | -217.57 | -254.15 | -292.21 | -120.11 | -320.59 | Upgrade
|
| Net Income to Common | -94.55 | -217.57 | -254.15 | -292.21 | -120.11 | -320.59 | Upgrade
|
| Shares Outstanding (Basic) | 52 | 49 | 36 | 23 | 23 | 23 | Upgrade
|
| Shares Outstanding (Diluted) | 52 | 49 | 36 | 23 | 23 | 23 | Upgrade
|
| Shares Change (YoY) | 12.76% | 38.27% | 51.65% | 0.56% | - | - | Upgrade
|
| EPS (Basic) | -1.82 | -4.42 | -7.13 | -12.44 | -5.14 | -13.72 | Upgrade
|
| EPS (Diluted) | -1.82 | -4.42 | -7.13 | -12.44 | -5.14 | -13.72 | Upgrade
|
| Free Cash Flow | -140.9 | -180.72 | -258.95 | -218.43 | -90.05 | -267.72 | Upgrade
|
| Free Cash Flow Per Share | -2.71 | -3.67 | -7.27 | -9.30 | -3.85 | -11.46 | Upgrade
|
| Gross Margin | -198.88% | -146.72% | -200.51% | - | -21.66% | - | Upgrade
|
| Operating Margin | -311.99% | -215.87% | -287.34% | -575.01% | -58.29% | -762.99% | Upgrade
|
| Profit Margin | -207.25% | -216.73% | -277.77% | -535.95% | -48.41% | -723.75% | Upgrade
|
| Free Cash Flow Margin | -308.85% | -180.03% | -283.02% | -400.63% | -36.29% | -604.39% | Upgrade
|
| EBITDA | -133.86 | -206.42 | -251.38 | -297.16 | -131.45 | -329.19 | Upgrade
|
| EBITDA Margin | -293.42% | -205.62% | -274.74% | - | -52.98% | - | Upgrade
|
| D&A For EBITDA | 8.47 | 10.29 | 11.53 | 16.35 | 13.19 | 8.79 | Upgrade
|
| EBIT | -142.33 | -216.7 | -262.91 | -313.51 | -144.64 | -337.97 | Upgrade
|
| EBIT Margin | - | -215.87% | -287.34% | - | -58.29% | - | Upgrade
|
| Revenue as Reported | 45.62 | 100.39 | 91.5 | 54.52 | 248.12 | 44.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.